Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Integral Diagnostics Limited as of June 30, 2025 is 627.22 MM.
- The operating income for Integral Diagnostics Limited as of June 30, 2025 is 57.93 MM.
- The net income for Integral Diagnostics Limited as of June 30, 2025 is 4.67 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 627.22 | 57.93 | 4.67 |
2025-03-31 | 559.27 | 50.55 | 5.17 |
2024-12-31 | 491.32 | 43.18 | 5.66 |
2024-09-30 | 480.51 | 42.67 | -27.52 |
2024-06-30 | 469.70 | 42.17 | -60.70 |
2024-03-31 | 463.01 | 41.33 | -59.28 |
2023-12-31 | 456.31 | 40.49 | -57.85 |
2023-09-30 | 448.54 | 39.48 | -16.41 |
2023-06-30 | 440.76 | 38.47 | 25.04 |
2023-03-31 | 417.93 | 36.69 | 22.79 |
2022-12-31 | 395.10 | 34.92 | 20.54 |
2022-09-30 | 378.01 | 36.77 | 17.57 |
2022-06-30 | 360.93 | 38.62 | 14.60 |
2022-03-31 | 360.70 | 37.59 | 18.09 |
2021-12-31 | 360.48 | 36.56 | 21.57 |
2021-09-30 | 355.59 | 42.97 | 26.42 |
2021-06-30 | 350.70 | 49.37 | 31.27 |
2021-03-31 | 332.76 | 49.51 | 31.66 |
2020-12-31 | 314.82 | 49.65 | 32.05 |
2020-09-30 | 295.19 | 44.04 | 27.54 |
2020-06-30 | |||
2020-03-31 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | 0.02 | 0.02 |
2024-09-30 | -0.12 | -0.12 |
2024-06-30 | -0.26 | -0.26 |
2024-03-31 | -0.25 | -0.26 |
2023-12-31 | -0.25 | -0.25 |
2023-09-30 | -0.07 | -0.07 |
2023-06-30 | 0.11 | 0.11 |
2023-03-31 | 0.10 | 0.10 |
2022-12-31 | 0.09 | 0.09 |
2022-09-30 | 0.08 | 0.08 |
2022-06-30 | 0.07 | 0.07 |
2022-03-31 | 0.09 | 0.09 |
2021-12-31 | 0.11 | 0.11 |
2021-09-30 | 0.13 | 0.13 |
2021-06-30 | 0.16 | 0.16 |
2021-03-31 | 0.16 | 0.16 |
2020-12-31 | 0.16 | 0.16 |
2020-09-30 | 0.14 | 0.14 |
2020-06-30 | 0.12 | 0.12 |
2020-03-31 | 0.13 | 0.12 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Integral Diagnostics Limited as of June 30, 2025 is 73.77 MM.
- The cash from investing activities for Integral Diagnostics Limited as of June 30, 2025 is -64.99 MM.
- The cash from financing activities for Integral Diagnostics Limited as of June 30, 2025 is 0.71 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 73.77 | -64.99 | 0.71 |
2025-03-31 | 73.45 | -54.72 | -7.08 |
2024-12-31 | 73.12 | -44.45 | -14.87 |
2024-09-30 | 69.64 | -36.18 | -22.16 |
2024-06-30 | 66.16 | -27.90 | -29.45 |
2024-03-31 | 62.03 | -37.10 | -29.37 |
2023-12-31 | 57.90 | -46.30 | -29.28 |
2023-09-30 | 62.59 | -87.63 | -28.43 |
2023-06-30 | 67.28 | -128.96 | -27.57 |
2023-03-31 | 56.13 | -122.45 | 12.34 |
2022-12-31 | 44.99 | -115.95 | 52.25 |
2022-09-30 | 41.04 | -85.82 | 66.69 |
2022-06-30 | 37.10 | -55.69 | 81.13 |
2022-03-31 | 40.64 | -53.48 | 37.50 |
2021-12-31 | 44.19 | -51.27 | -6.12 |
2021-09-30 | 56.88 | -53.97 | -6.98 |
2021-06-30 | 69.57 | -56.66 | -7.83 |
2021-03-31 | 72.67 | -55.03 | 5.78 |
2020-12-31 | 75.77 | -53.39 | 19.39 |
2020-09-30 | 65.01 | -73.46 | 47.40 |
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Management Effectiveness
- The roa for Integral Diagnostics Limited as of June 30, 2025 is 0.01.
- The roe for Integral Diagnostics Limited as of June 30, 2025 is 0.02.
- The roic for Integral Diagnostics Limited as of June 30, 2025 is 0.00.
- The croic for Integral Diagnostics Limited as of June 30, 2025 is 0.01.
- The ocroic for Integral Diagnostics Limited as of June 30, 2025 is 0.06.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | 0.01 | 0.02 | 0.00 | 0.01 | 0.06 |
2025-03-31 | 0.01 | 0.02 | 0.00 | 0.01 | 0.06 |
2024-12-31 | -0.08 | -0.20 | -0.09 | 0.01 | 0.10 |
2024-09-30 | -0.08 | -0.20 | -0.09 | 0.01 | 0.10 |
2024-06-30 | -0.16 | ||||
2024-03-31 | -0.16 | ||||
2023-12-31 | -0.04 | -0.12 | |||
2023-09-30 | 0.05 | -0.17 | |||
2023-06-30 | 0.07 | ||||
2023-03-31 | 0.07 | ||||
2022-12-31 | |||||
2022-09-30 | 0.00 | ||||
2022-06-30 | 0.00 | 0.00 | |||
2022-03-31 | 0.00 | ||||
2021-12-31 | 0.00 | ||||
2021-09-30 | 0.00 | 0.00 | |||
2021-06-30 | 0.05 | 0.06 | 0.01 | 0.12 | |
2021-03-31 | 0.05 | 0.14 | 0.06 | 0.04 | 0.13 |
2020-12-31 | 0.06 | 0.14 | 0.06 | 0.07 | 0.13 |
2020-09-30 | 0.05 | 0.12 | 0.05 | 0.07 | 0.12 |
2020-06-30 | 0.07 | 0.18 | 0.05 | 0.07 | 0.11 |
2020-03-31 | 0.07 | 0.17 | 0.04 | 0.04 | 0.09 |
Gross Margins
- The gross margin for Integral Diagnostics Limited as of June 30, 2025 is 0.32.
- The net margin for Integral Diagnostics Limited as of June 30, 2025 is 0.01.
- The operating margin for Integral Diagnostics Limited as of June 30, 2025 is 0.09.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | 0.32 | 0.01 | 0.09 |
2025-03-31 | 0.32 | 0.01 | 0.09 |
2024-12-31 | 0.32 | -0.13 | 0.09 |
2024-09-30 | 0.32 | -0.13 | 0.09 |
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | 0.06 | 0.09 | |
2023-06-30 | 0.06 | 0.09 | |
2023-03-31 | 0.05 | 0.09 | |
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | 0.00 | 0.00 | |
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | 0.37 | 0.09 | 0.14 |
2021-03-31 | 0.38 | 0.10 | 0.15 |
2020-12-31 | 0.38 | 0.10 | 0.16 |
2020-09-30 | 0.37 | 0.09 | 0.15 |
2020-06-30 | 0.36 | 0.08 | 0.14 |
2020-03-31 | 0.37 | 0.08 | 0.15 |
Identifiers and Descriptors
Central Index Key (CIK) |